You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Insulin Articles
Popular Insulin Articles
Highly Recommended Insulin Articles
Send a link to this page to your friends and colleagues.
The content for this column is furnished by the Iacocca Foundation
Over one year ago, Denise Faustman, MD, and her colleagues at Massachusetts General Hospital (MGH) eliminated type 1 diabetes in mice. The Iacocca Foundation wants this work to be translated to people who have new-onset or long-term diabetes. In order to achieve this goal, the Iacocca Foundation is raising the money to move the research from mice to humans in the hopes of finding a cure for human type 1 diabetes.
Previous Research Efforts
Most worldwide efforts have focused on three primary approaches to improve type 1 diabetes treatment and care.
Some researchers work only on pre-diabetic animals or humans to try to stop the disease prior to islet destruction. Unfortunately, this approach leaves the millions of people who already have diabetes without a new therapy for the future.
The second approach has been the transplantation of insulin-secreting islet cells in people with type 1 diabetes. The drawbacks of this approach are that islets are limited in supply, and these transplant procedures require immunosuppressive drugs, which can have a variety of side effects and leave the body prone to infection.
The third approach has been to work on treating the complications of type 1 diabetes, which is likely to create new treatments, not cures, for the disease.
And a Different Approach
Faustman and her colleagues have identified two compounds that were effective in killing the incorrectly functioning white blood cells that destroy insulin-producing cells in diabetic mice. Using these compounds, they produced a treatment that reversed type 1 diabetes in end-stage diabetic mice. No islet transplant was necessary to treat the disease once the incorrectly functioning white blood cells were killed. The islets regenerated on their own.
The findings at MGH open up new possibilities for people who already have diabetes. David M. Nathan, MD, of MGH will lead human clinical trials based on Faustman’s studies in mice in the hopes of eliminating diabetes and promoting islet regeneration. The researchers hope that once the defect in the immune system that causes diabetes is corrected and the destruction of insulin-producing cells is stopped, adult stem cells that are already within the body will regenerate insulin-producing cells. The regeneration of new islets will allow the body to create insulin and stabilize blood sugar levels.
How Can I Help?
Contribute to the Join Lee Now campaign and support these efforts to cure type 1 diabetes in humans. Donations may be made over the Internet or by mail.
Dec 1, 2004
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.